$AGEN Higher lows, might enter some time next. Already made huge profits in March.
Antigenics Inc. is a biotechnology company with immunotherapeutic vaccines in clinical trials in renal carcinoma, melanoma, and gastric and colorectal cancers. The Company's vaccines are based on technology that uses heat shock proteins to modulate the immune system. Antigenics' technology also has applications in infectious diseases and autoimmune disorders.